OncoVista Innovative Therapies, Inc. Updates with Comprehensive Shareholder Letter
SAN ANTONIO--(BUSINESS WIRE)--OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), a high-growth global biotech company developing proprietary, leading-edge early detection and drug technologies to enable safe, targeted personal cancer treatments, today released a letter to shareholders from Chief Executive Officer, Alexander L. Weis Ph.D. to update shareholders on the Company’s progress and potential.